BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2013

Mar 20, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2013-03-18

Reporting Person: BAFFI ROBERT (EVP, Technical Operations)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-03-18	Common Stock	M	20000	$14.39	Acquired	72350	Direct
2013-03-18	Common Stock	S	20000	$61.0180	Disposed	52350	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-03-18	Stock Option (right to buy) Common Stock	$14.39	M	20000	Disposed	2019-05-11	Common Stock (20000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	8238	Indirect

Footnotes

F1: Transaction made pursuant to a Rule 10b5-1 plan executed on March 4, 2013.

F2: The price in Column 4 is a weighted average price. The prices actually received ranged from $61.00 to $61.10. The reporting person will provide to the issuer, any security holder of the issuer, or SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F3: Options vest on November 12, 2009 and 1/48th on the 12th of each month thereafter.

F4: Reflects the number of stock options that remain outstanding from this specific stock option grant following the reported transaction.